{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:33:44Z","timestamp":1762508024352,"version":"3.37.3"},"reference-count":42,"publisher":"Veterinary World","issue":"3","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":70,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"am","delay-in-days":70,"URL":"http:\/\/veterinaryworld.org\/"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"tdm","delay-in-days":70,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["20190048"],"award-info":[{"award-number":["20190048"]}],"id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet World"],"published-print":{"date-parts":[[2020]]},"abstract":"<jats:p>Background and Aim: At present, there are no data about the efficacy of some recent antibiotics on Escherichia coli in broiler chickens in the study area. This study was designed to evaluate the in vitro and in vivo efficacy of cefepime, doripenem, tigecycline, and tetracycline against multidrug-resistant-extended-spectrum beta-lactamases (MDR-ESBLs) producing E. coli in broiler chicks. Materials and Methods: A total of 34 MDR-ESBLs E. coli isolates were used in this study. In vitro evaluation of the antibacterial efficacy of cefepime, doripenem, tigecycline, and tetracycline were performed using disk diffusion and minimum inhibitory concentration (MIC) assays. In vivo evaluation of the efficacy of the antibiotics was perfumed using 180, 2-week-old chicks challenged with MDR-ESBL-producing E. coli strain O78. Chicks were divided into six groups (30 chicks each) according to the treatment regimen. Treatment was administered to chicks in Groups 3-6 intravenously, twice per day for 1 week using one antibiotic per group at concentration 10 times the determined MIC. Chicks in the positive control (Group 1) were challenged and received 0.2 ml of sterile Tryptone Soy Broth (TSB), while those in the negative control (Group 2) were not challenged and received 0.2 ml of sterile TSB. The severity of clinical signs, gross lesions, and mortality rate was scored and compared between groups. Results: All E. coli isolates were sensitive to doripenem and tigecycline, while 88% were sensitive to cefepime and only 23% were sensitive to tetracycline. In vivo antibiotic efficacy evaluation in challenged chicks revealed a significant reduction in the severity of clinical signs, gross lesions, and mortality (3%) in chicks treated with cefepime compared to non-treated chicks (55%). There was no significant effect on the severity of clinical signs, gross lesions, and mortality in chicks treated with doripenem, tigecycline, and tetracycline compared to non-treated chicks. The mortality rates of chicks treated with doripenem, tigecycline, and tetracycline were 57%, 50%, and 90%, respectively. Conclusion: The results of this study indicate that most MDR-ESBLs producing E. coli isolates were sensitive to doripenem, tigecycline, and cefepime. However, in vivo study indicated that only cefepime was effective and resulted in a significant reduction in clinical signs, gross lesions, and mortality in infected chicks. Therefore, cefepime could be used to treat naturally infected chickens with MDR-ESBLs producing strains of E. coli.<\/jats:p>","DOI":"10.14202\/vetworld.2020.446-451","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T13:39:37Z","timestamp":1583933977000},"page":"446-451","source":"Crossref","is-referenced-by-count":3,"title":["In vitro and in vivo efficacy study of cefepime, doripenem, tigecycline, and tetracycline against extended-spectrum beta-lactamases Escherichia coli in chickens"],"prefix":"10.14202","volume":"13","author":[{"given":"Yaser Hamadeh","family":"Tarazi","sequence":"first","affiliation":[{"name":"Department of Basic Medical Veterinary Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab A.","family":"Abu-Basha","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Veterinary Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhair Bani","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawan A.","family":"Tailony","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Veterinary Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5308","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Prestinaci, F., Pezzotti, P. and Pantosti, A. (2015) Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health., 109(7): 309-318.","DOI":"10.1179\/2047773215y.0000000030"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Aslam, B., Wang, W., Arshad, M.I., Khurshid, M., Muzammil, S., Rasool, M.H., Nisar, M.A., Alvi, R.F., Aslam, M.A., Qamar, M.U., Salamat, M.K.F. and Baloch, Z. (2018) Antibiotic resistance: A rundown of a global crisis. Infect. Drug Resist., 10(11): 1645-1658.","DOI":"10.2147\/idr.s173867"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Tomley, F.M. and Shirley, M.W. (2009) Livestock infectious diseases and zoonoses. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 364(1530): 2637-2642.","DOI":"10.1098\/rstb.2009.0133"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Daikos, G.L., Tsaousi, S., Tzouvelekis, L.S., Anyfantis, I., Psichogiou, M., Argyropoulou, A., Stefanou, I., Sypsa, V., Miriagou, V., Nepka, M., Georgiadou, S., Markogiannakis, A., Goukos, D. and Skoutelis, A. (2014) Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: Lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob. Agents Chemother., 58(4): 2322-2328.","DOI":"10.1128\/aac.02166-13"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Russo, T.A. and Johnson, J.R. (2003) Medical and economic impact of extraintestinal infections due to Escherichia coli: Focus on an increasingly important endemic problem. Microbes Infect., 5(5): 449-456.","DOI":"10.1016\/s1286-4579(03)00049-2"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Rasheed, M.U., Thajuddin, N., Ahamed, P., Teklemariam, Z. and Jamil, K. (2014) Antimicrobial drug resistance in strains of Escherichia coli isolated from food sources. Rev. Inst. Med. Trop. Sao Paulo, 56(4): 341-346.","DOI":"10.1590\/s0036-46652014000400012"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Allocati, N., Masulli, M., Alexeyev, M.F. and Di Ilio, C. (2013) Escherichia coli in Europe: An overview. Int. J. Environ. Res. Public Health, 10(12): 6235-6254.","DOI":"10.3390\/ijerph10126235"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Li, B. and Webster, T.J. (2018) Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections. J. Marriage Fam., 57(2): 283-294.","DOI":"10.1002\/jor.23656"},{"key":"ref8","unstructured":"Singh, N., Madhu, M., Vanamail, P., Malik, N. and Kumar, S. (2017) Study of adverse drug reactions in patients with diabetes attending a tertiary care hospital in New Delhi, India. Indian J. Med. Res., 145(8): 247-249."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Hur, J., Jawale, C. and Lee, J.H. (2012) Antimicrobial resistance of Salmonella isolated from food animals: A review. Food Res. Int., 45(2): 819-830.","DOI":"10.1016\/j.foodres.2011.05.014"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Harada, K., Shimizu, T., Mukai, Y., Kuwajima, K., Sato, T. and Kataoka, Y. (2016) Phenotypic and molecular characterization of antimicrobial resistance in Klebsiella spp. isolates from companion animals in Japan: Clonal dissemination of multidrug-resistant extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae. Front. Microbiol., 7(7): 1-12.","DOI":"10.3389\/fmicb.2016.01021"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Davis, G.S., Waits, K., Nordstrom, L., Weaver, B., Aziz, M., Gauld, L. and Price, L.B. (2015) Intermingled Klebsiella pneumoniae populations between retail meats and human urinary tract Infections. Clin. Infec. Dis., 61(6): 892-899.","DOI":"10.1016\/j.juro.2016.12.018"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Guo, Y., Zhou, H., Qin, L., Pang, Z., Qin, T., Ren, H. and Zhou, J. (2016) Frequency, antimicrobial resistance and genetic diversity of Klebsiella pneumoniae in food samples. PLoS One, 11(4): 1-13.","DOI":"10.1371\/journal.pone.0153561"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Podder, M.P., Rogers, L., Daley, P.K., Keefe, G.P., Whitney, H.G. and Tahlan, K. (2014) Klebsiella species associated with bovine mastitis in Newfoundland. PLoS One, 9(9): 1-5.","DOI":"10.1371\/journal.pone.0106518"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Aloush, V., Navon-Venezia, S., Seigman-Igra, Y., Cabili, S. and Carmeli, Y. (2006) Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact. Antimicrob. Agents Chemother., 50(1): 43-48.","DOI":"10.1128\/aac.50.1.43-48.2006"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Hirsch, E.B. and Tam, V.H. (2010) Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev. Pharmacoecon. Outcomes Res., 66(3): 441-451.","DOI":"10.1586\/erp.10.49"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Katiyar, C., Gupta, A., Kanjilal, S. and Katiyar, S. (2012) Drug discovery from plant sources: An integrated approach. Ayu, 33(1): 10-19.","DOI":"10.4103\/0974-8520.100295"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Stein, G.E. and Babinchak, T. (2013) Tigecycline: An update. Diagn. Microbiol. Infect. Dis., 75(4): 331-336.","DOI":"10.1016\/j.diagmicrobio.2012.12.004"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Garrison, M.W., Neumiller, J. and Setter, S.M. (2005) Tigecycline: An investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms. PLoS One, 27(1): 25-73.","DOI":"10.1016\/j.clinthera.2005.01.007"},{"key":"ref19","unstructured":"Patel, H.B., Lusk, K.A. and Cota, J.M. (2017) The role of cefepime in the treatment of extended-spectrum beta-lactamase infections. J. Pharm. Pract., 55(2): 25-29."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Siedner, M.J., Galar, A., Guzm\u00e1n-Suarez, B.B., Kubiak, D.W., Baghdady, N., Ferraro, M.J. and Marty, F.M. (2014) Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia. Clin. Infec. Dis., 58(11): 1554-1563.","DOI":"10.1093\/cid\/ciu182"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Spellberg, B. and Gilbert, D.N. (2014) The future of antibiotics and resistance: A tribute to a career of leadership by John Bartlett. Clin. Infect. Dis., 59(2): S71-S75.","DOI":"10.1093\/cid\/ciu392"},{"key":"ref22","unstructured":"Clinical and Laboratory Standards Institute. (2011) Performance Standards for Antimicrobial Susceptibility Testing; 21st Informational Supplement. 3rd ed., Vol. 31. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"ref23","unstructured":"Wani, K.A., Thakur, M.A., Fayaz, S.A., Fomdia, B., Gulnaz, B. and Maroof, P. (2009) Extended-spectrum B-lactamase mediated resistance in Escherichia coli in a tertiary care hospital. Int. J. Health Sci., 3(2): 155-163."},{"key":"ref24","unstructured":"Walsh, F. (2007) Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities. Ther. Clin. Risk Manag., 3(5): 789-794."},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Troy, S., Muralidharan, G., Micalizzi, M., Speth, J. and Raible, D. (2005) Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Am. Soc. Microbiol., 78(1): 67-79.","DOI":"10.1128\/aac.49.1.220-229.2005"},{"key":"ref26","unstructured":"Calandra, D.M., Mauro, D.D., Cutugno, F. and Martino, S.D. (2016) Navigating wall-sized displays with the gaze: A proposal for cultural heritage. CEUR Workshop Proc., 1621(9): 36-43."},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Kabiru, L.M., Bello, M., Kabir, J., Grande, L. and Morabito, S. (2015) Detection of pathogenic Escherichia coli in samples collected at an abattoir in Zaria, Nigeria and at different points in the surrounding environment. Int. J. Environ. Res. Public Health, 12(1): 679-691.","DOI":"10.3390\/ijerph120100679"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Shah, S.A.A., Akhter, N., Auckloo, B.N., Khan, I., Lu, Y., Wang, K., Wu, B. and Guo, Y. (2017) Structural diversity, biological properties and applications of natural products from cyanobacteria. A review. Mar. Drugs, 15(11): 354.","DOI":"10.3390\/md15110354"},{"key":"ref29","unstructured":"Van der Waaij, E.H. (2017) Escherichia coli pathogenicity and lesions in broiler chickens in Spain. Vet. Rec., 128(7): 244-258."},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Wang, Z., Qin, R.R., Huang, L. and Sun, L.Y. (2018) Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and mortality of Klebsiella pneumoniae Infection. Chin. Med. J., 131(1): 56-59.","DOI":"10.4103\/0366-6999.221267"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"M\u00fcller, P., Alber, D.G., Turnbull, L., Schlothauer, R.C., Carter, D.A., Whitchurch, C.B. and Harry, E.J. (2013) Synergism between medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA). PLoS One, 8(2): 1-9.","DOI":"10.1371\/journal.pone.0057679"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Erdem, H., Kili\u00e7, S. and Pahsa, A. (2013) Gram-negative bacterial resistance to cephalosporins in community-acquired infections in Turkey. J. Chemother., 17(2): 2-15.","DOI":"10.1179\/joc.2005.17.1.61"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Ito, A., Hirai, K., Innoue, M., Koga, H., Suzue, S., Irikura, T. and Mitsuhash, S. (1980) In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob. Agents Chemother., 17(2): 103-107.","DOI":"10.1128\/aac.17.2.103"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Martinez, J.L. (2014) General principles of antibiotic resistance in bacteria. Drug Discov. Today Technol., 11(2): 33-39.","DOI":"10.1016\/j.ddtec.2014.02.001"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Mansouri, M., Ramazanzadeh, R. and Norabadi, P. (2011) Cefepime resistance and associated risk factors among Escherichia coli strains isolated from clinical specimens. Chemotherapy, 57(2): 134-137.","DOI":"10.1159\/000323623"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Wang, Q., Zhang, P., Zhao, D., Jiang, Y., Zhao, F., Wang, Y., Li, X., Du, X. and Yu, Y. (2018) Emergence of tigecycline resistance in Escherichia coli co-producing MCR-1 and NDM-5 during tigecycline salvage treatment. Infect. Drug Resist., 13(11): 2241-2248.","DOI":"10.2147\/idr.s179618"},{"key":"ref37","unstructured":"Lowbury, E.J.L., Thom, B.T., Lily, B.T.J., Babb, R. and Wittal, K. (2010) Source of infection with Pseudomonas aeruginosa in patients with tracheotomy. J. Clin. Microbiol., 3(3): 39-56."},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Ibrahim, R.A., Cryer, T.L., Lafi, S.Q., Abu Basha, E., Good, L. and Tarazi, Y.H. (2019) Identification of Escherichia coli from broiler chickens in Jordan, their antimicrobial resistance, gene characterization and the associated risk factors. BMC Vet. Res., 15(5): 159-161.","DOI":"10.1186\/s12917-019-1901-1"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Samonis, G., Maraki, S., Karageorgopoulos, D.E., Vouloumanou, E.K. and Falagas, M.E. (2012) Synergy of fosfomycin with Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur. J. Clin. Microbiol. Infect. Dis., 31(4): 695-701.","DOI":"10.1007\/s10096-011-1360-5"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Al-Bahry, S.N., Al-Mashani, B.M., Al-Ansari, A.S., Elshafie, A.E. and Mahmoud, I.Y. (2013) Escherichia coli tetracycline efflux determinants in relation to tetracycline residues in chicken. Asian Pac. J. Trop. Med., 6(3): 718-722.","DOI":"10.1016\/s1995-7645(13)60125-x"},{"key":"ref41","unstructured":"Morita, Y., Tomida, J. and Kawamura, Y. (2013) Responses of Pseudomonas aeruginosa to antimicrobials. Front. Microbiol., 4(3): 422-428."}],"container-title":["Veterinary World"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.veterinaryworld.org\/Vol.13\/March-2020\/8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.13\/March-2020\/8.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.13\/March-2020\/8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:19:17Z","timestamp":1695907157000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.veterinaryworld.org\/Vol.13\/March-2020\/8.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":42,"issue-title":["March-2020"],"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]},"published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.14202\/vetworld.2020.446-451","relation":{},"ISSN":["2231-0916","0972-8988"],"issn-type":[{"type":"electronic","value":"2231-0916"},{"type":"print","value":"0972-8988"}],"subject":[],"published":{"date-parts":[[2020]]}}}